Investigation of the factors responsible for the low oral bioavailability of alizarin using a sensitive LC-MS/MS method: In vitro, in situ, and in vivo evaluations.
Drug Dev Res
; 84(3): 579-591, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-36811607
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Tandem Mass Spectrometry
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Drug Dev Res
Year:
2023
Document type:
Article
Affiliation country:
South Korea
Country of publication:
United States